SOUTH EASTON, Mass., Aug. 8 /PRNewswire-FirstCall/ -- Pressure
BioSciences, Inc. (Nasdaq: PBIO) today announced that the Company will host a
teleconference to discuss its second quarter 2008 financial results and to
provide a business update. Anyone interested may listen to the teleconference
either by telephone or through a live web-cast. The teleconference and web-
cast information is provided below:
To attend this teleconference via telephone:
Dial-in: (877) 719-9795
Participant code: 4491004
For those unable to participate in the live teleconference, a replay will
be available approximately one hour after the call ends through September 15,
2008, and will be accessible through the Company's website:
www.pressurebiosciences.com
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBI) is a publicly-traded company focused on
the development, and commercialization, of a novel, enabling technology called
Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure
between ambient and ultra-high levels (up to 35,000 psi and greater) to
control bio-molecular interactions. PBI currently holds 13 US and 6 foreign
patents covering multiple applications of PCT in the life sciences' field,
including such areas as genomic and proteomic sample preparation, pathogen
inactivation, the control of chemical reactions, immunodiagnostics, and
protein purification.
Investor Contacts:
Richard T. Schumacher, President & CEO
Edward H. Myles, Senior Vice President of Finance & CFO
Pressure BioSciences, Inc.
(T) 508-230-1828
.gif)
